Literature DB >> 26542261

A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.

V Fernández1, S Estein2, P Ortiz3, P Luchessi2, V Solana4, H Solana4.   

Abstract

The helminth parasite Fasciola hepatica causes fascioliasis in human and domestic ruminants. Economic losses due to this infection are estimated in U$S 2000-3000 million yearly. The most common method of control is the use of anthelmintic drugs. However, there is an increased concern about the growing appearance of F. hepatica resistance to Triclabendazole (TCBZ), an anthelmintic with activity over adult and young flukes. F. hepatica has eight Glutathione S-Transferase (GST) isozymes, which are enzymes involved in the detoxification of a wide range of substrates through chemical conjugation with glutathione. In the present work we identified and characterized the GST mu gene isolated from the TCBZ-susceptible and TCBZ-resistant F. hepatica strains. Total RNA was transcribed into cDNA by reverse transcription and a 657 bp amplicon corresponding to the GST mu gene was obtained. The comparative genetic analysis of the GST mu gene of the TCBZ susceptible strain (Cullompton) and TCBZ resistant strain (Sligo) showed three nucleotide changes and one amino acid change at position 143 in the GST mu isozyme of the TCBZ-resistant strain. These results have potential relevance as they contribute better understand the mechanisms that generate resistance to anthelmintics.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fasciola hepatica; Glutathione S-Transferases mu; Isozyme; Triclabendazole

Mesh:

Substances:

Year:  2015        PMID: 26542261     DOI: 10.1016/j.exppara.2015.10.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

1.  Field study on the determination of the effective dose of injectable fosfatriclaben prodrug in sheep naturally infected with Fasciola hepatica.

Authors:  Froylán Ibarra-Velarde; Tania Rojas-Campos; Yolanda Vera-Montenegro; Miguel Flores-Ramos; Rafael Castillo; Gerardo Leyva-Gómez
Journal:  Parasitol Res       Date:  2021-11-05       Impact factor: 2.289

2.  Assessment of Fasciola hepatica glutathione S-transferase as an antigen for serodiagnosis of human chronic fascioliasis.

Authors:  Vasti Aguayo; Bianca Valdes; Ana M Espino
Journal:  Acta Trop       Date:  2018-07-07       Impact factor: 3.112

3.  The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica.

Authors:  Rebekah B Stuart; Suzanne Zwaanswijk; Neil D MacKintosh; Boontarikaan Witikornkul; Peter M Brophy; Russell M Morphew
Journal:  Parasitol Res       Date:  2021-01-27       Impact factor: 2.289

4.  Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis.

Authors:  Richard Lalor; Krystyna Cwiklinski; Nichola Eliza Davies Calvani; Amber Dorey; Siobhán Hamon; Jesús López Corrales; John Pius Dalton; Carolina De Marco Verissimo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 5.  Drug resistance in liver flukes.

Authors:  I Fairweather; G P Brennan; R E B Hanna; M W Robinson; P J Skuce
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-01-10       Impact factor: 4.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.